Delivery Order SPE2DB20D2104-SPE2DB20FR53C
- Not listed
- The federal contract award is for a prime vendor pharmaceutical contract with the Defense Logistics Agency (DLA) awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,710.00 and is a firm fixed price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., has an Indefinite Delivery Contract (IDC) with...
- This federal contract award is for a Prime Vendor Pharmaceutical delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,139.40 delivery order is a firm-fixed-price contract that supports the DLA Troop Support Medical program. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The federal contract award is for a prime vendor pharmaceutical contract with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $1,499.14. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen). This contract is a delivery order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), which has a ceiling value of up to $999,999,999.00 and runs through December 2025....
- This federal contract award is for a prime vendor pharmaceutical supply contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,274.77 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award is for a prime vendor pharmaceutical contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,810.29 delivery order was issued by the Defense Logistics Agency (DLA) to support the DLA Troop Support Medical program. The contract provides a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, across various therapeutic areas....
- This federal contract award is for a prime vendor pharmaceutical distribution contract with the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,338.43 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up...
- This federal contract award is for a prime vendor pharmaceutical distribution contract, valued at $1,139.24, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This is an open competition contract, with no set-aside designation....
- This federal contract award is for a prime vendor pharmaceutical distribution contract with the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,003.31, is a delivery order placed under a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a prime vendor pharmaceutical supply service for the DLA Troop Support Medical. The contract, valued at $1,646.14, is a Firm Fixed Price delivery order that runs through August 2020. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award is for a prime vendor pharmaceutical distribution contract with the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $34,479.79, provides a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB20FR53CDelivery Order
This federal contract award is for a prime vendor pharmaceutical supply contract with the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,004.89, is a delivery order with a firm fixed price pricing type and has no set-aside designation, indicating open competition. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/23/20 |